The Latest
This Week in HIV Research: New Keys to the Care Continuum
Sept. 12, 2019: Better virologic outcomes at coordinated walk-in facilities offering incentives; same-day PrEP initiation at STD clinics; U=U and "low drug regimens"; adherence trends among perinatally infected adolescents.
This Week in HIV Research: What's in a Blip?
Aug. 29, 2019: Viral load blips, low-level viremia, and eventual virologic failure; pinpointing non-adherence as a cause of HIV treatment failure; HIV care costs vary widely throughout U.S.; Kaposi sarcoma incidence in the modern HIV treatment era.
Large Scale HIV Vaccine Trial Announced, But PrEP May Challenge Enrollment
Will potential study participants choose a vaccine trial over getting access to PrEP?
The Next Frontier of U=U Science
Undetectable equals untransmittable (U=U) has improved HIV prevention and tackled stigma, but there are still a few questions to answer.
Gay Men Cannot Get HIV From Partners Who Are Virally Suppressed, New Study Proves
Results from the PARTNER2 study, presented by Alison Rodger at AIDS 2018, yielded an equivalent level of confidence for gay men as it had for heterosexual couples in the original PARTNER study several years ago.
No HIV Transmissions in Couples With Positive Partner Undetectable on Treatment
HIV-positive individuals with a viral load below 200 while on antiretroviral therapy did not transmit HIV to steady sex partners during more than one year of condomless sex.
Treatment as Prevention Could Nearly Eliminate HIV in MSM, Danish Study Predicts
Antiretroviral treatment as prevention (TasP) in Denmark could nearly eliminate the HIV epidemic among men who have sex with men (MSM), according to predictions of a Bayesian back-calculation model.
Negligible Risk: Updated Results From Two Studies Continue to Show That Antiretroviral Treatment and an Undetectable Viral Load Is a Highly Effective HIV Prevention Strategy
Interim analyses from two important studies clearly demonstrated that ART and an undetectable viral load is a highly effective HIV prevention strategy for heterosexual and gay male serodiscordant couples.
HPTN 052: No Partner Infections With Viral Suppression
Final results revealed a 93% reduction in sexual HIV transmission within serodiscordant couples when the individual with HIV was taking antiretroviral therapy.
Real-World Antiretroviral Therapy as Prevention: A Top HIV Clinical Development of 2014
In a well-designed and rigorously executed clinical trial, people living with HIV who started antiretroviral therapy had a significantly lower risk of transmitting the virus to their partners compared to those assigned to wait to start HIV treatment....